Brian Mann
-
The $20 million settlement involving the drugmaker and two Ohio counties comes as a massive federal trial is scheduled to begin in the state later this month.
-
"The Sackler family does not belong in bankruptcy court," Rep. Max Rose said of Purdue Pharma's owners. "They belong in handcuffs." He and others want charges for drug companies linked to the crisis.
-
As the cases proceed, critics say blame for the addiction crisis should be shared by government officials, who saw that opioid sales were skyrocketing years ago but failed to raise the alarm.
-
The New York state attorney general says the Sackler family has transferred $1 billion overseas as it negotiated a settlement over its company, Purdue Pharma, the maker of OxyContin.
-
Purdue Pharma, the company that makes Oxycontin, has reached a tentative deal to settle thousands of lawsuits stemming from the country's opioid epidemic. Some state officials may not agree to the terms of the deal.
-
A group of state attorneys general negotiating with members of the Sackler family says they expect Purdue Pharma to file for bankruptcy "imminently," according to an email obtained by NPR.
-
Purdue Pharma, Johnson & Johnson and other health care giants are discussing potential deals with authorities that could resolve thousands of lawsuits they're facing over the U.S. opioid epidemic.
-
A court order that Johnson and Johnson pay Oklahoma $572 million for its role in the opioid crisis is good news for the other state and local governments bringing cases against the opioid industry.
-
In a landmark ruling, Judge Thad Balkman ruled in favor of Oklahoma in its lawsuit to hold the drugmaker accountable for the costs of opioid addiction in the state.
-
The first major opioid trial in the country wraps up Monday. An Oklahoma judge will rule in a $17 billion civil suit filed by the state against Johnson & Johnson.